相关实验视频
Updated: Jun 25, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
839
血小板-纤维素凝块强度和血小板反应性预测皮肤冠状动脉干预后心血管事件
Osung Kwon1,2, Jong-Hwa Ahn3, Jin-Sin Koh4
1Division of Cardiology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
European heart journal
|May 28, 2024
概括
在接受皮肤冠状动脉干预 (PCI) 的患者中,血小板-纤维素凝块强度 (PFCS) 和高血小板反应率 (HPR) 对主要不良心血管事件 (MACE) 有添加效应. 综合评估改善了个性化抗血栓治疗的风险分层.
科学领域:
- 心血管医学 心血管医学
- 血液学 血液学 血液学
- 干预心脏病学 干预心脏病学
背景情况:
- 血小板纤维素凝块强度 (PFCS) 与主要不良心血管事件 (MACE) 风险相关.
- 在皮肤冠状动脉干预 (PCI) 患者中,PFCS和血小板活性对预后的影响尚未完全理解.
研究的目的:
- 为了研究PFCS,血小板反应性和PCI患者的临床结果之间的关联.
- 为了确定MACE和出血风险的联合PFCS和血小板反应性评估的预后值.
主要方法:
- 一项基于登记册的研究,涉及韩国2512名PCI患者 (2010-2018年).
- 通过VerifyNow.Now测量PFCS的血小板表和血小板活性.
- 患者分为四组:正常/高PFCS和正常/高血小板反应.
主要成果:
- 高的PFCS和高血小板反应率 (HPR) 显示对MACE风险产生添加效应 (P < .001).
- 在HPR-PFCSHigh组的MACE发病率明显高 (19.3%) 与正常-正常组 (7.5%) 相比.
- 与HPR-PFCS正常表型相比,正常的PFCS表型与较大的出血风险相关.
结论:
- PFCS和血小板活性是PCI患者临床预后的关键预测因素.
- 对PFCS和血小板活性的联合评估提高了个性化抗血小板策略的风险分层.
相关概念视频
Clot Retraction and Fibrinolysis
5.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.5K
Formation of the Platelet Plug
5.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.8K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
521
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
521
Structure and Function of Platelets
1.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K
Introduction to Hemostasis
7.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.3K

